Evidence map›Paper›PMID 41016820›Full record

ArticleJournal of microbiology and biotechnology2025

Heat-Treated

Minji Kang, Minkyoung Kang, Moon-Hee Sung, Jong-Hoon Kim, Juyeon Lee, Kwangcheol Casey Jeong, Sangnam Oh

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Minji KangDepartment of Environmental Science and Biotechnology, Jeonju University, Jeonju 55069, Republic of Korea.
Minkyoung KangDepartment of Environmental Science and Biotechnology, Jeonju University, Jeonju 55069, Republic of Korea.
Moon-Hee SungKookminBio Corporation, Seoul 02826, Republic of Korea.
Jong-Hoon KimKookminBio Corporation, Seoul 02826, Republic of Korea.
Juyeon LeeKookminBio Corporation, Seoul 02826, Republic of Korea.
Kwangcheol Casey JeongEmerging Pathogens Institute, University of Florida, Gainesville, FL 32611, USA.
Sangnam OhDepartment of Environmental Science and Biotechnology, Jeonju University, Jeonju 55069, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcopenia, a progressive loss of skeletal muscle mass and function, poses a significant health concern in aging populations and cancer patients. Despite ongoing pharmaceutical research, including drug repurposing strategies, no FDA-approved treatment is currently available for sarcopenia, highlighting the need for safer, food-derived interventions. This study evaluated the anti-aging and muscle-preserving effects of KLP_KM2, a postbiotic formulation derived from

Indexed as

Lactiplantibacillus plantarumMuscular AtrophyProbioticsAnimalsCaenorhabditis elegansCell LineFermentationHot TemperatureLongevityMiceMuscle Fibers, SkeletalMuscle, SkeletalSarcopeniacancer cachexiaC. elegansLactiplantibacillus plantarum KM2postbioticssarcopenia

Identifiers

PMID41016820
PMCPMC12535864

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.